Utility of the WHO dengue guidelines in pediatric immunological studies
Journal of Tropical Pediatrics · 2024
DOI: 10.1093/tropej/fmae014 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Tropical Pediatrics, 2024. Verfasst von Jorge L Sánchez und 4 weiteren Autor:innen. Beteiligte Einrichtung: División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva 41001, Colombia. Hauptthemen laut MEDLINE: Dengue, World Health Organization, Interleukin-6, Interleukin-8. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Convocatoria de menor cuantía.
Abstract (Originalsprache)
Dengue is a significant health problem due to the high burden of critical infections during outbreaks. In 1997, the World Health Organization (WHO) classified dengue as dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). It was revised in 2009 (updated in 2015), and the new guidelines recommended classifying patients as dengue without warning signs (DNS), dengue with warning signs (DWS), and severe dengue (SD). Although the utility of the revised 2009 classification for clinical studies is accepted, for immunological studies it needs to be clarified. We determined the usefulness of the 2009 classification for pediatric studies that analyze the circulating interleukin (IL)-6 and IL-8, two inflammatory cytokines. Plasma levels of IL-6 and IL-8 were evaluated in the acute and convalescent phases by flow cytometry in children with dengue classified using the 1997 and 2009 WHO guidelines. The plasma levels of IL-6 and IL-8 were elevated during the acute and decreased during convalescence, and both cytokines served as a good marker of acute dengue illness compared to convalescence. There were no differences in the plasma level of the evaluated cytokines among children with different clinical severity with any classification, except for the IL-8, which was higher in DWS than DNS. Based on the levels of IL-8, the 2009 classification identified DWS plus SD (hospital-treated children) compared to the DNS group [area under the curve (AUC): 0.7, p = 0.028]. These results support the utility of the revised 2009 (updated in 2015) classification in studies of immune markers in pediatric dengue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva 41001, Colombia.
- Departamento de Pediatría, Universidad Surcolombiana, Hospital Universitario de Neiva, Neiva 41001, Colombia.
ORCID-Profile: Carlos F Narváez
Förderung
- Convocatoria de menor cuantía
Zitieren
APA
Sánchez, J. L., Salgado, D. M., Vega, M. R., Castro-Trujillo, S., & Narváez, C. F. (2024). Utility of the WHO dengue guidelines in pediatric immunological studies. Journal of Tropical Pediatrics. https://doi.org/10.1093/tropej/fmae014
Vancouver
Sánchez JL, Salgado DM, Vega MR, Castro-Trujillo S, Narváez CF. Utility of the WHO dengue guidelines in pediatric immunological studies. Journal of Tropical Pediatrics. 2024. doi:10.1093/tropej/fmae014
BibTeX
@article{Snchez2024,
author = {Sánchez, Jorge L and Salgado, Doris M and Vega, Martha Rocío and Castro-Trujillo, Sebastián and Narváez, Carlos F},
title = {Utility of the WHO dengue guidelines in pediatric immunological studies},
journal = {Journal of Tropical Pediatrics},
year = {2024},
doi = {10.1093/tropej/fmae014}
}
EUVIMED